{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T05:10:10Z","timestamp":1772169010151,"version":"3.50.1"},"reference-count":13,"publisher":"F1000 Research Ltd","license":[{"start":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T00:00:00Z","timestamp":1604016000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["f1000research.com"],"crossmark-restriction":false},"short-container-title":["F1000Res"],"abstract":"<ns3:p>\n                    <ns3:bold>Background:<\/ns3:bold>\n                    Electronic devices for measuring blood pressure (BP) need to go through independent clinical validation as recommended by different authorities, both in general and specific populations. The aim of this study was to assess the validity of the Omron RS6 (HEM-6221-E) wrist oscillometric devices in obese Sudanese patients.\n                  <\/ns3:p>\n                  <ns3:p>\n                    <ns3:bold>Methods:<\/ns3:bold>\n                    Of 90 obese individuals invited for recruitment, 33 were included in the study, and had their BP at the level of the wrist measured using Omron RS6 and standard mercury sphygmomanometer. Two observations were made and the mean was taken. BP differences between the two methods for the 33 participants were classified into three categories (\u22645, \u226410, and \u226415 mmHg), according to the European Society of Hypertension-International Protocol revision 2010 (ESH-IP2) criteria. This was then used to assess the validity of the tested Omron RS6 device.\n                  <\/ns3:p>\n                  <ns3:p>\n                    <ns3:bold>Results:<\/ns3:bold>\n                    Participants had a mean age of 56.97 years (standard deviation (SD), 8.75; range, 36-79). Average systolic blood pressure (SBP) was 146.21 mmHg (SD, 23.07; range, 107-182), and average diastolic blood pressure (DBP) was 93.82 mmHg (SD, 16.06; range, 67-128). There was a good agreement between the two observations using the OMRON RS6 and the standard sphygmomanometer: \u22124 to + 3 mmHg for SBP and \u22124 to +4 mmHg for DBP, with the mean difference of 1.73\u00b11.11 mmHg for SBP and 1.49\u00b11.02 mmHg for DBP.\n                  <\/ns3:p>\n                  <ns3:p>\n                    <ns3:bold>Conclusion:<\/ns3:bold>\n                    Thus, the Omron RS6 (HEM-6221-E) is a valid and suitable measure of BP according to ESH-IP2.\n                  <\/ns3:p>","DOI":"10.12688\/f1000research.26442.1","type":"journal-article","created":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T23:28:37Z","timestamp":1633822117000},"page":"1284","update-policy":"https:\/\/doi.org\/10.12688\/f1000research.crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Validation of the wrist blood pressure measuring device Omron RS6 (HEM-6221-E) among obese Sudanese patients according to the European Society of Hypertension International Protocol Revision 2010"],"prefix":"10.12688","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8967-433X","authenticated-orcid":false,"given":"Elrazi A.","family":"Ali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5031-7741","authenticated-orcid":false,"given":"Saeed M.","family":"Omar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yassin","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osama","family":"Al-Wutayd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5031-7741","authenticated-orcid":false,"given":"Ishag","family":"Adam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2560","published-online":{"date-parts":[[2020,10,30]]},"reference":[{"key":"ref-1","article-title":"A global brief on Hypertension WHO 2013","volume":"18","year":"2013"},{"key":"ref-2","doi-asserted-by":"publisher","first-page":"801-812","DOI":"10.1016\/S0140-6736(14)61468-9","article-title":"Hypertension.","volume":"386","author":"N Poulter","year":"2015","journal-title":"Lancet."},{"key":"ref-3","doi-asserted-by":"publisher","first-page":"600-609","DOI":"10.1016\/j.amepre.2010.02.016","article-title":"Deaths preventable in the U.S. by improvements in use of clinical preventive services.","volume":"38","author":"T Farley","year":"2010","journal-title":"Am J Prev Med."},{"key":"ref-4","doi-asserted-by":"publisher","first-page":"259-261","DOI":"10.1097\/MBP.0000000000000191","article-title":"Validation of the Grandway MD2301 digital automatic blood pressure monitor according to the European Society of Hypertension International Protocol.","volume":"21","author":"W Chen","year":"2016","journal-title":"Blood Press Monit."},{"key":"ref-5","doi-asserted-by":"publisher","first-page":"61-69","DOI":"10.2147\/VHRM.S126285","article-title":"Questionable accuracy of home blood pressure measurements in the obese population - Validation of the Microlife WatchBP O3\u00ae and Omron RS6\u00ae devices according to the European Society of Hypertension-International Protocol.","volume":"13","author":"A Azaki","year":"2017","journal-title":"Vasc Health Risk Manag."},{"key":"ref-6","doi-asserted-by":"publisher","first-page":"14-33","DOI":"10.1111\/jch.12049","article-title":"Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment: a position paper of The Obesity Society and the American Society of Hypertension.","volume":"15","author":"L Landsberg","year":"2013","journal-title":"J Clin Hypertens (Greenwich)."},{"key":"ref-7","doi-asserted-by":"publisher","first-page":"101-106","DOI":"10.1097\/00126097-200306000-00002","article-title":"Effect of standard cuff on blood pressure readings in patients with obese arms. How frequent are arms of a 'large circumference'?","volume":"8","author":"S Fonseca-Reyes","year":"2003","journal-title":"Blood Press Monit."},{"key":"ref-8","doi-asserted-by":"publisher","first-page":"101-105","DOI":"10.1097\/01.mbp.0000132425.25263.ac","article-title":"Blood pressure measurement in obese patients: comparison between upper arm and forearm measurements.","volume":"9","author":"A Pierin","year":"2004","journal-title":"Blood Press Monit."},{"key":"ref-9","doi-asserted-by":"publisher","first-page":"23-38","DOI":"10.1097\/MBP.0b013e3283360e98","article-title":"European Society of Hypertension International Protocol revision 2010 for the validation of blood pressure measuring devices in adults.","volume":"15","author":"E O\u2019Brien","year":"2010","journal-title":"Blood Press Monit."},{"key":"ref-10","doi-asserted-by":"publisher","first-page":"1832-1837","DOI":"10.1097\/HJH.0000000000002106","article-title":"Reproducibility of the European Society of Hypertension - International Protocol for validation of blood pressure measuring devices in obese patients.","volume":"37","author":"D Tasic","year":"2019","journal-title":"J Hypertens."},{"key":"ref-11","doi-asserted-by":"publisher","first-page":"265-272","DOI":"10.2147\/VHRM.S44569","article-title":"Validation of Omron RS8, RS6, and RS3 home blood pressure monitoring devices, in accordance with the European Society of Hypertension International Protocol revision 2010.","volume":"9","author":"H Takahashi","year":"2013","journal-title":"Vasc Health Risk Manag."},{"key":"ref-12","doi-asserted-by":"publisher","first-page":"306-313","DOI":"10.1097\/MBP.0000000000000063","article-title":"Comparison of the Omron RS6 wrist blood pressure monitor with the positioning sensor on or off with a standard mercury sphygmomanometer.","volume":"19","author":"C Deutsch","year":"2014","journal-title":"Blood Press Monit."},{"key":"ref-13","article-title":"Validation of the wrist blood pressure measuring device Omron RS6 (HEM-6221-E) among obeseoObese Sudanese patients compared with a standard mercury sphygmomanometer: a cross-sectional study ElrazipPatients according to the European Society of Hypertension International Protocol Revision 2010","author":"I Adam","year":"2020"}],"container-title":["F1000Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/f1000research.com\/articles\/9-1284\/v1\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/9-1284\/v1\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/9-1284\/v1\/iparadigms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T13:12:15Z","timestamp":1645621935000},"score":1,"resource":{"primary":{"URL":"https:\/\/f1000research.com\/articles\/9-1284\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,30]]},"references-count":13,"URL":"https:\/\/doi.org\/10.12688\/f1000research.26442.1","relation":{"has-review":[{"id-type":"doi","id":"10.5256\/f1000research.29192.r95237","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.29192.r87886","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.29192.r95237","asserted-by":"object"},{"id-type":"doi","id":"10.5256\/f1000research.29192.r87886","asserted-by":"object"}]},"ISSN":["2046-1402"],"issn-type":[{"value":"2046-1402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,30]]},"assertion":[{"value":"Indexed","URL":"https:\/\/f1000research.com\/articles\/9-1284\/v1#article-reports","order":0,"name":"referee-status","label":"Referee status","group":{"name":"current-referee-status","label":"Current Referee Status"}},{"value":"10.5256\/f1000research.29192.r87886, James A Hodgkinson, Institute of Applied Health Research, University of Birmingham, Edgbaston, Birmingham, UK, 12 Jul 2021, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/9-1284\/v1#referee-response-87886","order":0,"name":"referee-response-87886","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.29192.r95237, Yoshio Iwashima, Division of Hypertension and Nephrology, Dokkyo Medical University, Tochigi, Japan, 08 Oct 2021, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/9-1284\/v1#referee-response-95237","order":1,"name":"referee-response-95237","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"The author(s) declared that no grants were involved in supporting this work","order":2,"name":"grant-information","label":"Grant Information"},{"value":"This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.","order":0,"name":"copyright-info","label":"Copyright"}]}}